Skip to content
sellWeak

Christopher Mirabelli sold $43k of CYPH

Chairman of the Board at LEAP THERAPEUTICS, INC.. 60,000 shares at an average of $0.71, traded Mar 26, 2026, filed Mar 30, 2026.

Warning score
31
Value
$43k
60,000 shares
Holdings after
130,376
-32% from before
From 52-week low
+180%
low $0.24, close $0.68
From 52-week high
-77%
high $2.97, as of Mar 26, 2026

Score components

  • Role
    Director
    +15
  • Trade size
    $43k at market
    +6
  • Share of holdings sold
    Sold 32% of holdings
    +10
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +35.8%, 3m +1.4%, 6m +428.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CYPHOct 12, 2026 · close 2.90
Since filing Mar 30, 2026: +363.3%SPY +23.7% · excess +339.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001104659-26-036804, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 26, 2026SOpen-market sale
Common Stock
-60,000$0.71$43k130,376Mar 30, 2026

Related signals

Other insiders at LEAP THERAPEUTICS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
45Moderate
CYPHsell 2
LEAP THERAPEUTICS, INC.
Patricia A. Martin
director
$193k
50,000 shares
-30%
63Notable
CYPHsell 2
LEAP THERAPEUTICS, INC.
Khing Djien Oei
director
$662k
168,750 shares
-100%
26Weak
CYPHsell
LEAP THERAPEUTICS, INC.
Thomas John Dietz
director
$34k
20,000 shares
-13%
73Notable
CYPHsell 3
LEAP THERAPEUTICS, INC.
James H Cavanaugh
director
$822k
261,840 shares
-100%
85Strong
CYPHsell 3
LEAP THERAPEUTICS, INC.
Douglas E Onsi
CEO,CFO,Pres.,GC,Treas.&Sec.
$2.1M
676,319 shares
-100%
75Notable
CYPHsell 3
LEAP THERAPEUTICS, INC.
Christopher Mirabelli
Chairman of the Board
$2.1M
676,319 shares
-100%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Christopher Mirabelli sold $43k of CYPH | InsiderTell